These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10770423)

  • 1. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
    Barr ML; Baker CJ; Schenkel FA; McLaughlin SN; Stouch BC; Starnes VA; Rose EA
    Clin Transplant; 2000 Apr; 14(2):162-6. PubMed ID: 10770423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.
    Barr ML; Meiser BM; Eisen HJ; Roberts RF; Livi U; Dall'Amico R; Dorent R; Rogers JG; Radovancević B; Taylor DO; Jeevanandam V; Marboe CC
    N Engl J Med; 1998 Dec; 339(24):1744-51. PubMed ID: 9845709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients.
    Arruda JA; Costa MA; Brito FS; Tedesco H; Barbosa AH; Ribeiro EP; Pestana JO; Lima VC
    Am J Cardiol; 2003 Jun; 91(11):1363-5. PubMed ID: 12767437
    [No Abstract]   [Full Text] [Related]  

  • 4. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
    Eisen H
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii9-13. PubMed ID: 16815858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
    Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
    Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
    Kahan BD
    Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection.
    Dall'Amico R; Livi U; Milano A; Montini G; Andreetta B; Murer L; Zacchello G; Thiene G; Casarotto D; Zacchello F
    Transplantation; 1995 Jul; 60(1):45-9. PubMed ID: 7624941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients.
    Indudhara R; Khauli RB; Menon M; Stoff JS
    J Urol; 1994 Aug; 152(2 Pt 1):307-11. PubMed ID: 8015058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
    Swenson JM; Fricker FJ; Armitage JM
    J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
    Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
    Mehra MR; Ventura HO; Jain SP; Ramireddy K; Ali A; Stapleton DD; Smart FW; Ramee SR; Collins TJ; White CJ
    J Am Coll Cardiol; 1997 May; 29(6):1339-44. PubMed ID: 9137233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
    Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N
    Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression.
    Elias TJ; Bannister KM; Clarkson AR; Russ GR; Mathew TH; Barratt LJ; Faull RJ
    Clin Transplant; 2000 Apr; 14(2):157-61. PubMed ID: 10770422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.